Home > > > Report Detail

Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024

Publisher Name :
Date: 23-Aug-2019
No. of pages: 125
Inquire Before Buying

Increasing focus on risk management solutions is expected to drive the growth of the clinical risk grouping solutions market

The clinical risk grouping solutions market is projected to reach USD 829 million by 2024 from USD 427 million in 2019, at a CAGR of 14.2%. Focus on risk management and big data solutions are driving the market for clinical risk grouping solutions. However, a lack of infrastructure for supporting this technology is expected to restrain the growth of the market to a certain extent during the forecast period.

Dashboard analytics segment to show the fastest growth during the forecast period

Based on product, the clinical risk grouping solutions market is segmented into three major categories, viz., scorecard & visualization tools, dashboard analytics, and risk reporting. The dashboard analytics segment is expected to witness one of the highest CAGR within the clinical risk grouping solutions market. High adoption of dashboard analytics by healthcare providers, the increasing adoption of risk management solutions in the healthcare industry, growing requirements for accuracy & quality of patient care, and the rising use of big data solutions in healthcare are driving the growth of the segment.

Private cloud to hold the largest share of the clinical risk grouping solutions market during the forecast period

Based on the deployment model, the clinical risk grouping solutions market is segmented into private cloud, public cloud, and hybrid cloud. In 2018, the private cloud segment accounted for the dominant share of the clinical risk grouping solutions market. The large share of this segment is attributed to the fact that private cloud deployment offers the best security for sensitive data. Additionally, a private cloud offers on-demand infrastructure with dedicated resources that can be shared across domains, applications, and units within the same organization.

North America accounted for the largest share of the market in 2018, whereas the Asia Pacific is expected to be the fastest-growing market

The study discusses the clinical risk grouping solutions market trends for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the global clinical risk grouping solutions market. The large share of North America can be attributed to the support for adopting HCIT by providers and payers, increasing focus on population health services, and greater availability of clinical risk grouping solutions

However, Asia Pacific is expected to be the fastest-growing market with the highest CAGR during the forecast period. Factors such as the presence of a larger patient population demanding better healthcare at lower costs, economic growth, rising geriatric population, emergence of big data in healthcare, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the clinical risk grouping solutions market in the Asia Pacific.

The breakup of primary participants is as mentioned below:


  • By Company Type: Tier 1 (50%), Tier 2 (10%), and Tier 3 (40%)

  • By Designation: C-level (10%), Director-level (30%), and Others (60%)

  • By Region: North America (40%), Europe (30%), Asia Pacific (10%), Latin America (10%), and the Middle East and Africa (10%)


The prominent players in the global clinical risk grouping solutions market are 3M Corporation (US), Optum Inc. (US), Cerner Corporation (US), Conduent Inc. (US), Nuance Communications (US), Health Catalyst (US), HBI Solutions (US), Johns Hopkins University (US), Lightbeam Health Solutions (US), Dynamic Healthcare Systems (US), 4S Information Systems (US), Evolent Health (US), and PeraHealth (US).

Research Coverage:

The report analyzes the clinical risk grouping solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product, deployment model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios of the top players in the global clinical risk grouping solutions market. The report analyzes this market by product, deployment model, end-user, and region

  • Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global clinical risk grouping solutions market

  • Market Development: Comprehensive information on the lucrative emerging markets by product, deployment model, end-user, and region

  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global clinical risk grouping solutions market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global clinical risk grouping solutions market

Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Clinical Risk Grouping Solutions: Market Overview
4.2 Clinical Risk Grouping Solutions Market: Geographic Growth Opportunities
4.3 Regional Mix: Market (2019–2024)
4.4 Market: Developed Vs. Developing Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Focus on Risk Management
5.2.1.2 Rising Usage of Big Data Solutions
5.2.2 Restraints
5.2.2.1 Lack of Infrastructure
5.2.3 Opportunities
5.2.3.1 Increasing Physician Burnout Due to Documentation Needs
5.2.3.2 Increasing Focus on Ai and Machine Learning
5.2.4 Challenges
5.2.4.1 Scarcity of Skilled Healthcare IT Professionals
5.2.4.2 Patient Data Privacy Concerns
5.2.5 Burning Issue
5.2.5.1 Implementation of Solutions Reduces Administrative Expenses But Increases the Burden on Patients

6 Clinical Risk Grouping Solutions Market, By Product
6.1 Introduction
6.2 Scorecards & Visualization Tools
6.2.1 Need to Increase Patient Accuracy and Forecast Risks are Driving Demand for Scorecards & Visualization Tools
6.3 Dashboard Analytics Solutions
6.3.1 Dashboard Analytics Segment to Register the Highest Growth During the Forecast Period
6.4 Risk Reporting Solutions
6.4.1 Increasing Adoption of Risk Management Solutions By Healthcare Providers to Fuel Market Growth

7 Clinical Risk Grouping Solutions Market, By Deployment Model
7.1 Introduction
7.2 Private Cloud
7.2.1 High Data Security of Private Cloud Models is Driving Market Growth
7.3 Public Cloud
7.3.1 Price-Effectiveness of Public Over Private Clouds has Driven End-User Preference
7.4 Hybrid Cloud
7.4.1 Hybrid Cloud Architecture Provide Flexibility and the Ability to Avoid Vendor Lock-In

8 Clinical Risk Grouping Solutions Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals are the Largest End Users of the Clinical Risk Grouping Solutions Market
8.3 Payers
8.3.1 Payers use Clinical Risk Grouping Solutions for Risk Management, Identifying Claims Trends, and Maximizing Payment Accuracy
8.4 Ambulatory Care Centers
8.4.1 Implementation of Mandates to Comply With Quality Measures to Support the Adoption of Clinical Risk Grouping Solutions in Ambulatory Care Centers
8.5 Long-Term Care Centers
8.5.1 Growing Number of Long-Term Care Centers to Drive Market Growth
8.6 Other End Users

9 Clinical Risk Grouping Solutions Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the North American Market
9.2.2 Canada
9.2.2.1 Growing Need for Cost Containment in Healthcare Will Propel Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Infrastructural Development and Focus on Risk Management Have Driven Market Growth in Germany
9.3.2 UK
9.3.2.1 Favorable Regulatory Outlook has Pushed the Adoption of Hcit Solutions in the UK
9.3.3 France
9.3.3.1 Initiatives Taken By the French Government to Promote the use of Healthcare IT Solutions Will Drive Market Growth
9.3.4 Rest of Europe (RoE)
9.4 Asia Pacific
9.4.1 Asia is Expected to Witness High Growth in Population and Demand for Healthcare Services
9.5 Latin America
9.5.1 Countries Such as Brazil and Mexico are Exploring New Methods to Manage Clinical Information
9.6 Middle East and Africa
9.6.1 Middle Eastern Countries are Investing Significantly in Hcit Infrastructural Development

10 Competitive Landscape
10.1 Introduction
10.2 Company Analysis, By Product and End User
10.3 Competitive Situations and Trends

11 Company Profile
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 3M Company
11.2 Optum Inc. (Subsidiary of Unitedhealth Group Inc.)
11.3 Nuance Communications
11.4 Conduent Incorporated
11.5 Cerner Corporation
11.6 HBI Solutions, Inc.
11.7 4S Information Systems Ltd.
11.8 Johns Hopkins University
11.9 Lightbeam Health Solutions, LLC
11.10 Dynamic Healthcare Systems, Inc.
11.11 Perahealth, Inc.
11.12 Health Catalyst Inc.
11.13 Evolent Health

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Market Sizing & Validation Approach
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables

Table 1 Exchange Rates Utilized for Conversion to USD
Table 2 Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 3 Scorecards and Visualization Tools: Key Brands
Table 4 Scorecards & Visualization Tools Market, By Region, 2017–2024 (USD Million)
Table 5 Dashboard Analytics: Key Brands
Table 6 Dashboard Analytics Solutions Market, By Region, 2017–2024 (USD Million)
Table 7 Risk Reporting: Key Brands
Table 8 Risk Reporting Solutions Market, By Region, 2017–2024 (USD Million)
Table 9 ons Market, By Deployment Model, 2017–2024 (USD Million)
Table 10 Private Cloud-Deployed Market, By Country/Region, 2017–2024 (USD Million)
Table 11 Public Cloud-Deployed Clinical Risk Grouping Solutions Market, By Country/Region, 2017–2024 (USD Million)
Table 12 Hybrid Cloud-Deployed Market, By Country/Region, 2017–2024 (USD Million)
Table 13 Market, By End User, 2017–2024 (USD Million)
Table 14 Clinical Risk Grouping Solutions for Hospitals
Table 15 Market for Hospitals, By Country/Region, 2017–2024 (USD Million)
Table 16 Clinical Risk Grouping Solutions for Payers
Table 17 Market for Payers, By Country/Region, 2017–2024 (USD Million)
Table 18 Clinical Risk Grouping Solutions for Ambulatory Care Centers
Table 19 Market for Ambulatory Care Centers, By Country/Region, 2017–2024 (USD Million)
Table 20 Clinical Risk Grouping Solutions for Long-Term Care Centers
Table 21 Clinical Risk Grouping Solutions Market for Long-Term Care Centers, By Country/Region, 2017–2024 (USD Million)
Table 22 Market for Other End Users, By Country/Region, 2017–2024 (USD Million)
Table 23 Market, By Region, 2017–2024 (USD Million)
Table 24 North America: Market, By Country, 2017–2024 (USD Million)
Table 25 North America: Market, By Product, 2017–2024 (USD Million)
Table 26 North America: Market, By Deployment Model, 2017–2024 (USD Million)
Table 27 North America: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 28 US: Key Macroindicators
Table 29 US: Market, By Product, 2017–2024 (USD Million)
Table 30 US: Market, By Deployment Model, 2017–2024 (USD Million)
Table 31 US: Market, By End User, 2017–2024 (USD Million)
Table 32 Canada: Key Macroindicators
Table 33 Canada: Market, By Product, 2017–2024 (USD Million)
Table 34 Canada: Market, By Deployment Model, 2017–2024 (USD Million)
Table 35 Canada: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 36 Europe: Market, By Country, 2017–2024 (USD Million)
Table 37 Europe: Market, By Product, 2017–2024 (USD Million)
Table 38 Europe: Market, By Deployment Model, 2017–2024 (USD Million)
Table 39 Europe: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 40 Germany: Key Macroindicators
Table 41 Germany: Market, By Product, 2017–2024 (USD Million)
Table 42 Germany: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 43 Germany: Market, By End User, 2017–2024 (USD Million)
Table 44 UK: Key Macroindicators
Table 45 UK: Market, By Product, 2017–2024 (USD Million)
Table 46 UK: Market, By Deployment Model, 2017–2024 (USD Million)
Table 47 UK: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 48 France: Market, By Product, 2017–2024 (USD Million)
Table 49 France: Market, By Deployment Model, 2017–2024 (USD Million)
Table 50 France: Market, By End User, 2017–2024 (USD Million)
Table 51 RoE: Market, By Product, 2017–2024 (USD Million)
Table 52 RoE: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 53 RoE: Market, By End User, 2017–2024 (USD Million)
Table 54 Asia Pacific: Market, By Product, 2017–2024 (USD Million)
Table 55 Asia Pacific: Market, By Deployment Model, 2017–2024 (USD Million)
Table 56 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 57 Latin America: Market, By Product, 2017–2024 (USD Million)
Table 58 Latin America: Market, By Deployment Model, 2017–2024 (USD Million)
Table 59 Latin America: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 60 Middle East and Africa: Market, By Product, 2017–2024 (USD Million)
Table 61 Middle East and Africa: Market, By Deployment Model, 2017–2024 (USD Million)
Table 62 Middle East and Africa: Market, By End User, 2017–2024 (USD Million)
Table 63 Product Launches and Enhancements (2017–2019)
Table 64 Acquisitions, Joint Ventures, and Mergers (2018–2019)
Table 65 Collaborations, Agreements, and Partnerships (2018–2019)
Table 66 Expansions (2017)

List of Figures

Figure 1 Clinical Risk Grouping Solutions Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Clinical Risk Grouping Solutions Market, By Product, 2019 Vs. 2024 (USD Million)
Figure 8 Market, By Deployment Model, 2019 Vs. 2024 (USD Million)
Figure 9 Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 10 Geographical Snapshot of the Market
Figure 11 Increasing Focus on Risk Management is the Major Factor Driving the Adoption of Clinical Risk Grouping Solutions
Figure 12 Asia Pacific Market to Register the Highest Growth During the Forecast Period
Figure 13 North America Will Continue to Dominate the Market in 2024
Figure 14 Asia Pacific Market to Register Higher Growth Rates During the Forecast Period
Figure 15 Market: Drivers, Restraints, Opportunities & Challenges
Figure 16 Healthcare Data Breaches in the US (2016-2019)
Figure 17 Scorecard and Visualization Tools Segment to Dominate the Market in 2019
Figure 18 Private Cloud to Hold the Largest Share of the Market During the Forecast Period
Figure 19 Clinical Risk Grouping Solutions Market, By End User, 2019 Vs. 2024
Figure 20 Market: Geographic Snapshot
Figure 21 North America: Market Snapshot
Figure 22 Europe: Snapshot
Figure 23 Key Developments in the Market Between 2016 and 2019
Figure 24 3M and Optum are the Leading Players in the Market
Figure 25 3M Company: Company Snapshot
Figure 26 Optum Inc.: Company Snapshot
Figure 27 Nuance Communications: Company Snapshot
Figure 28 Conduent Incorporated: Company Snapshot
Figure 29 Cerner: Company Snapshot
Figure 30 Evolent Health: Company Snapshot

  • Global Surgical Overalls Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
  • Global Medical or Healthcare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
  • Global Hospital Gas Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Nurse Call Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period. The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
  • Global Pediatric Healthcare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
  • Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Telepharmacy market: According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
  • Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 115
    Market Overview of Global Vinca Alkaloid Compounds market: According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
  • Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Bladder Cancer market: According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years. Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 115
    Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market: According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs